FMP
NASDAQ
0.479 USD
-0.0046 (-0.96%)
Mr. Gregory Duncan
Healthcare
Biotechnology
https://www.virios.com
NASDAQ
Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Virios Therapeutics, LLC and changed its name to Virios Therapeutics, Inc. in December 2020. Virios Therapeutics, Inc. was founded in 2012 and i...
0001818844
US92829J1043
92829J104
44 Milton Avenue
866 620 8655
US
4
Dec 17, 2020
0001818844
NASDAQ
Biotechnology
Healthcare
92829J104
US92829J1043
US
0.48
1.83
389.68k
9.23M
-
0.279-2.42
0.18
-
-
-
-
-1.71
-
https://www.virios.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.